Swedish-based biopharmaceutical company Hansa Medical plans to acquire the rights to cancer immunotherapy using antibody modulating enzymes, through the acquisition of glycobiology therapeutic antibodies developer Immago Biosystems Ltd.

Immago Biosystems is a spinout company of the University of Oxford.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

Specialist pharmaceutical company Knight Therapeutics has acquired an additional 15.8% stake in Canadian-based pharmaceutical company Pediapharm, to become an 18.5% stakeholder of the company.

Upon completion of the transaction, Knight Therapeutics will hold 757,500 warrants that are convertible into common shares of Pediapharm at any time until March 2019.

Pharmaceutical Technology Excellence Awards - The Benefits of Entering

Gain the recognition you deserve! The Pharmaceutical Technology Excellence Awards celebrate innovation, leadership, and impact. By entering, you showcase your achievements, elevate your industry profile, and position yourself among top leaders driving pharmaceutical advancements. Don’t miss your chance to stand out—submit your entry today!

Nominate Now